17.700
−0,56%
2026-10-19
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +188.3% | +1695.7% | 3 / 3 | +0.9% | +15.56 pp | +13.15 pp | +12.3% | 0.08 | 15.92 | 43,0 | +0,9% | 8,6 | +197,9% | 15.92 | 58.33 | −72,7% |
| Pts | 12 | 12 | 12 | 0 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 17.700 (close price on 2026-10-19)EPS (TTM): 1.112
Financial charts
1.Revenue & growth
VND bn43,0Q2/26
1.Revenue & growth
VND bn43,0Q2/26
2.Profit & growth
VND bn7,37Q2/26
3.Profit mix (Penman)
VND bn44,9Q2/26
4.Margins & cost structure
%14.4%Q2/26
5.Returns & cash cycle
% · days4.5%Q2/26
6.Earnings quality & cash
VND bn62,7Q2/26
7.Asset structure
VND bn729Q2/26
8.Funding & debt health
VND bn · times729Q2/26
9.Revenue backlog
VND bn2,93Q2/26
10.Valuation
times · %15,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %205Q2/26
Adjusted EPS growth, latest quarter
188%
Average adjusted EPS growth, 3 quarters
116%
averaged over 2 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26